News
-
-
-
-
-
-
PRESS RELEASE
MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition
MIRA Pharmaceuticals announced new preclinical results for SKNY-1, an oral drug candidate targeting obesity and nicotine addiction, showing promise in reducing anxiety-like effects. The drug may offer a novel treatment approach for weight loss and craving management -
-
-
PRESS RELEASE
HORNBACH Holding AG & Co. KGaA: Annual General Meeting approves dividend of EUR 2.40 – solid performance in past financial year
HORNBACH Holding AG & Co. KGaA's Annual General Meeting approves dividend of EUR 2.40 for the 2024/25 financial year, with a distribution quota of 27.3%. CEO optimistic about future prospects -
